中文别名 |
司帕沙星;顺-5-氨基-1-环丙基-6,8-二氟一1,4-二氢-7-(3,5-二甲基-1-哌嗪基)-4-氧代-3-喹啉羧酸;5-氨基-1-环丙基-7-(顺式-3,5-二甲基-1-哌嗪基)-6,8-二氟-1,4-二氢-4-氧代-3-喹啉羧酸;司氟沙星;苏柏沙星;司帕沙星溶液;司帕沙星(司氟沙星);普尼拉明;司帕沙星 标准品;5-氨基-1-环丙基-7-(cis-3,5-二甲基-1-哌嗪基)-6,8-二氟-1,4-二氢-4-氧代喹啉-3-羧酸;磷酸丙吡胺;司帕沙星(标准品);司帕沙星溶液,100PPM;司帕沙星溶液, 1000PPM;司帕沙星溶液, 100UG/ML 甲醇溶液;司帕沙星溶液, 1000UG/ML 甲醇溶液;司帕沙星BR;司帕沙星(分析标准品);斯帕沙星;司帕沙星(对照品) |
英文别名 |
Sparfloxacin;5-AMINO-1-CYCLOHEXYL-7-(CIS-3,5-DIMETHYLPIPERAZINO)-6,8-DIFLUORO-1,4-DIHYDRO-4-OXO-3-QUINOLINECARBOXYLIC ACID;at4140;ci978;Clorsulon, Vetranal;3-Quinolinecarboxylic acid, 5-amino-1-cyclopropyl-7-(3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxo-, cis-;3-Quinolinecarboxylic acid, 5-amino-1-cyclopropyl-7-[(3R,5S)-3,5-dimethyl-1-piperazinyl]-6,8-difluoro-1,4-dihydro-4-oxo-, rel- (9CI);3-QUINOLINECARBOXYLIC ACID, 5-AMINO-1-;5-amino-1-cyclopropyl-7-(3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid;5-amino-1-cyclopropyl-7-[(3R,5S)-3,5-dimethylpiperazin-1-yl]-6,8-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid;cis-5-amino-1-cyclopropyl-7-(3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid;MMOL, DELIVERED >;Parox;PD 1315-1;Sparcin;Sparfloxaci;SPARFLOXACIN, [2-14C]- 5-25 MCI(185-925 MBQ);SULFAMIC ACID;Zagam;Spara;RP-64206;CP 103826;Sparfloxacinum;Sparfloxacine;Esparfloxacino;CI 978;AT 4140;Sparfloxacine [INN-French];Sparfloxacinum [INN-Latin];SPFX;Esparfloxacino [INN-Spanish];PD 131501;Q90AGA787L;5-Amino-1-cyclopropyl-7-(cis-3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydr;cis-5-Amino-1-cyclopropyl-7-(3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid;5-Amino-1-cyclopropyl-7-(cis-3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid;CI-978;AT-4140;5-Amino-1-cyclopropyl-7-(cis-3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic Acid;5-amino-1-cyclopropyl-7-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-6,8-difluoro-4-oxo-quinoline-3-carboxylic acid;s1884;DB01208;Tox21_111580_1;Q976559;BRD-K07612980-001-07-9;NCGC00166294-03;3-Quinolinecarboxylic acid, 5-amino-1-cyclopropyl-7-[(3R,5S)-3,5-dimethyl-1-piperazinyl]-6,8-difluoro-1,4-dihydro-4-oxo-, rel-;AKOS005622503;BRD-K07612980-001-04-6;NCGC00166294-02;AB00639950-02;SPARFLOXACIN [ORANGE BOOK];AB00639950_03;CAS-110871-86-8;SPARFLOXACIN [MI];Sparfloxacin & RU 40555;BDBM50366822;PD-131501;111542-93-9;NSC-759641;BCP23886;SR-05000001521;5-amino-1-cyclopropyl-7-[(3S,5R)-3,5-dimethyl-1-piperazinyl]-6,8-difluoro-4-oxo-3-quinolinecarboxylic acid;Tox21_111580;GTPL10860;HMS2090N19;Sparfloxacinum (INN-Latin);MFCD00869619;AT-4140 pound>>CI-978 pound>>CI 978 pound>>CI978 pound>>AT 4140 pound>>AT4140 pound>>PD 131501 pound>>PD131501 pound>>PD-131501;110871-86-8;BBL010957;Sparfloxacin, >=98.0% (HPLC);HMS3715J13;Sparfloxacin, VETRANAL(TM), analytical standard;Sparfloxacin [USAN:INN:BAN:JAN];SPARFLOXACIN [USAN];NSC 759641;SMR000466312;D00590;Esparfloxacino (INN-Spanish);J01MA09;HY-B0308;DTXSID9023590;MLS000759417;Z1590783391;5-amino-1-cyclopropyl-7-((3R,5S)-3,5-dimethylpiperazin-1-yl)-6,8-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid;AC-11574;S0896;DTXCID50820154;SR-05000001521-2;SR-01000759357-2;5-Amino-1-cyclopr... |